• Arcus Biosciences, Inc. (NYSE:RCUS) Receives Average Rating of "Buy" from Analysts

    Source: Buzz FX / 07 Nov 2024 01:12:16   America/Chicago


    Arcus Biosciences, Inc. (NYSE:RCUS) Receives Average Rating of "Buy" from Analysts Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Arcus Biosciences, Inc. ( NYSE:RCUS - Get Free Report ) has earned a consensus rating
    Read more...
Share on,